ReviewTranslational lung cancer research2019
Mitigating the adverse health effects and costs associated with smoking after a cancer diagnosis.
Review in Translational lung cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 15 citations in OpenAlex.
- Aged Garlic Extract and Its Bioactive Molecules S-Allyl-Cysteine and S1-Propenyl-Cysteine: A Review Focusing on Evidences Supporting Their Use for Mitigating the Effects of Cigarette Smoking.Molecules (Basel, Switzerland) · 2025Review
- Specialty Tobacco Treatment Implementation in Oncology: A Qualitative Study.JCO oncology practice · 2025Article
- Integrating Tobacco Treatment Into Oncology Care: Reach and Effectiveness of Evidence-Based Tobacco Treatment Across National Cancer Institute-Designated Cancer Centers.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023Article
- Does neighborhood or residence influence continued smoking among cancer patients: a spatial-ecological and descriptive analyses brief report.Cancer causes & control : CCC · 2023Article
- Increasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion program.Cancer causes & control : CCC · 2023Review
- Lessons from Cost-Effectiveness Analysis of Smoking Cessation Programs for Cancer Patients.Current oncology (Toronto, Ont.) · 2022Review
- Operationalizing Leadership and Clinician Buy-In to Implement Evidence-Based Tobacco Treatment Programs in Routine Oncology Care: A Mixed-Method Study of the U.S. Cancer Center Cessation Initiative.Current oncology (Toronto, Ont.) · 2022Article
- The cost of failed first-line cancer treatment related to continued smoking in Canada.Current oncology (Toronto, Ont.) · 2020Article
- Responses of smoking and nonsmoking cancer patients to drug treatment: A protocol for systematic review and meta-analysis.Medicine · 2020Article
- Article
- PD-1/PD-L1 inhibitors as a hope for smokers of non-small cell lung cancer patient.Translational cancer research · 2019Article
- Using information technology to integrate tobacco use treatment in routine oncology care: Lessons learned from the U.S. Cancer Center Cessation Initiative Cancer Centers.Implementation research and practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Smoking after a cancer diagnosis causes adverse outcomes and is associated with substantial additional treatment cost. Mitigation of the adverse effects of smoking require active commitment from health systems, providers, and patients. Three areas of mitigation are discussed: (I) smoking cessation after a cancer diagnosis to improve cancer treatment outcomes; (II) identifying optimal cancer treatment strategies for patients who smoke at the time of diagnosis; and (III) how health systems can prioritize the effect modification caused by smoking. As innovation continues for healthcare delivery, priority should be placed on interventions that reduce the effect modification and associated costs caused by continued smoking after a cancer diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.